Association of Fenofibrate Therapy With Long-term Cardiovascular Risk in Statin-Treated Patients With Type 2 Diabetes-Reference-Cited by-同舟云学术

Association of Fenofibrate Therapy With Long-term Cardiovascular Risk in Statin-Treated Patients With Type 2 Diabetes

Published:2017-04-01 Issue:4 Volume:2 Page:370
ISSN:2380-6583
Container-title:JAMA Cardiology
language:en
Short-container-title:JAMA Cardiol

Author:

Elam Marshall B.¹,Ginsberg Henry N.²,Lovato Laura C.³,Corson Marshall⁴,Largay Joseph⁵,Leiter Lawrence A.⁶,Lopez Carlos²,O’Connor Patrick J.⁷,Sweeney Mary Ellen⁸,Weiss Daniel⁹,Friedewald William T.²,Buse John B.⁵,Gerstein Hertzel C.¹⁰,Probstfield Jeffrey⁴,Grimm Richard¹¹,Ismail-Beigi Faramarz¹²,Goff David C.¹³,Fleg Jerome L.¹⁴,Rosenberg Yves¹⁴,Byington Robert P.³,

Affiliation:

1. Memphis Veterans Affairs Medical Center and University of Tennessee Health Sciences Center, Memphis

2. Columbia University College of Physicians and Surgeons, New York, New York

3. Wake Forest School of Medicine, Wake Forest, North Carolina

4. University of Washington, Seattle

5. University of North Carolina, Chapel Hill

6. Li Ka Shing Knowledge Institute and Keenan Research Centre for Biomedical Science, St. Michael's Hospital, University of Toronto, Ontario, Canada

7. HealthPartners Institute, Minneapolis, Minnesota

8. Atlanta Veterans Affairs Medical Center, Atlanta, Georgia

9. Diabetes Endocrine Nutrition Group, Mentor, Ohio

10. McMaster Medical Center, Hamilton, Ontario, Canada

11. Berman Center for Outcomes and Clinical Research, Minneapolis, Minnesota

12. Cleveland Veterans Affairs Medical Center, Cleveland, Ohio

13. Colorado School of Public Health, Aurora, Colorado

14. National Heart, Lung, and Blood Institute, Division of Cardiovascular Sciences, Bethesda, Maryland

Publisher

American Medical Association (AMA)

Subject

Cardiology and Cardiovascular Medicine

Reference41 articles.

1. The independent effect of type 2 diabetes mellitus on ischemic heart disease, stroke, and death: a population-based study of 13,000 men and women with 20 years of follow-up.;Almdal;Arch Intern Med,2004

2. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial.;Stamler;Diabetes Care,1993

3. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction.;Haffner;N Engl J Med,1998

4. Impact of diabetes on mortality after the first myocardial infarction.;Miettinen;Diabetes Care,1998

5. Diabetic dyslipidemia.;Chahil;Endocrinol Metab Clin North Am,2006

Cited by 139 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pemafibrate;Clinical Lipidology;2024

2. Is there still a place for fenofibrate-statin combination therapy?;European Atherosclerosis Journal;2023-12-31

3. Can Concurrent Fibrate Use Reduce Cardiovascular Risks among Moderate Chronic Kidney Disease Patients Undergoing Statin Therapy? A Cohort Study;Journal of Clinical Medicine;2023-12-28

4. Bibliometric analysis of residual cardiovascular risk: trends and frontiers;Journal of Health, Population and Nutrition;2023-11-28

5. Effect of omega-3 fatty acids supplementation on the prognosis of coronary artery disease: A meta-analysis of randomized controlled trials;Nutrition, Metabolism and Cardiovascular Diseases;2023-11